Katharina Spanaus Selected Research

Biomarkers (Surrogate Marker)

12/2022	Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic Stroke.
1/2015	Urinary biomarkers at early ADPKD disease stage.
1/2015	Plasma Proendothelin-1 as an Early Marker of Bronchopulmonary Dysplasia.
1/2014	ICG-liver test versus new biomarkers as prognostic markers for prolonged length of stay in critically ill patients - a prospective study of accuracy for prediction of length of stay in the ICU.
1/2013	Early serum procalcitonin level after primary total hip replacement.
1/2009	Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katharina Spanaus Research Topics

Disease

2	Ischemic Stroke 12/2022 - 01/2021
2	Stroke (Strokes) 12/2022 - 01/2021
2	Chronic Hepatitis C 01/2018 - 05/2017
2	Infections 01/2018 - 01/2013
2	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2015 - 01/2009
1	Myocardial Infarction 12/2022
1	Atrial Fibrillation 12/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Atherosclerosis 01/2021
1	Hypoxia (Hypoxemia) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Liver Diseases (Liver Disease) 01/2018
1	Hairy Cell Leukemia 05/2017
1	Mood Disorders (Mood Disorder) 01/2017
1	Rupture 10/2016
1	Pulmonary Hypertension 01/2015
1	Hypoaldosteronism (Hyporeninemic Hypoaldosteronism) 01/2015
1	Lung Injury 01/2015
1	Bronchopulmonary Dysplasia 01/2015
1	Critical Illness (Critically Ill) 01/2014
1	Prostatic Neoplasms (Prostate Cancer) 01/2013
1	Insulin Resistance 02/2011
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2011
1	Marfan Syndrome (Marfan's Syndrome) 12/2010
1	Loeys-Dietz Syndrome 12/2010
1	Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos) 12/2010
1	Hypertension (High Blood Pressure) 01/2009
1	Albuminuria 01/2009

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2009
1	omega-Chloroacetophenone (Mace)IBA 12/2022
1	Atrial Natriuretic Factor (ANF)IBA 12/2022
1	Lipoprotein(a)IBA 01/2021
1	Chelating AgentsIBA 01/2019
1	Deferoxamine (Desferal)FDA LinkGeneric 01/2019
1	Ferritins (Ferritin)IBA 01/2019
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2019
1	IronIBA 01/2019
1	Interferon-gamma (Interferon, gamma)IBA 01/2018
1	Bile Acids and Salts (Bile Acids)IBA 01/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	InterferonsIBA 05/2017
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2017
1	Oxytocin (Pitocin)FDA LinkGeneric 10/2016
1	AldosteroneIBA 01/2015
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 01/2015
1	proendothelin 1IBA 01/2015
1	ReninIBA 01/2015
1	ProcalcitoninIBA 01/2013
1	AdiponectinIBA 02/2011
1	Transforming Growth Factor-beta Type II ReceptorIBA 12/2010
1	Transforming Growth Factor-beta Type I ReceptorIBA 12/2010
1	CreatinineIBA 01/2009

Therapy/Procedure

2	Therapeutics 01/2018 - 05/2017
1	Drug Therapy (Chemotherapy) 05/2017
1	Length of Stay 01/2014
1	Castration 01/2013